COMPARE-Diabetes will establish core outcome measures for trials of Type 1 Diabetes Mellitus in children.
The outcomes will be developed based on shared priorities between patients, families and caregivers, clinicians, researchers, policymakers and other relevant stakeholders.
Prof Geoffrey Ambler
Dr Shubha Srinivasan
A/Prof Allison Tong
Ms Camilla Hanson
The process is based on the methods used in many other research areas, in particular the Outcome Measures in Rheumatology (OMERACT) initiative and the World Health Organisation (WHO)-endorsed OMERACT framework. This process is underpinned by the values of: partnership, transparency, equity, trust, respect, evidence, and diversity.
Each ‘domain’ will run individually under the guidance of the COMPARE steering group. For example, the COMPARE-Diabetes group will develop core outcomes for trials related to paediatric diabetes.
There is a five phase process to the creation of a core outcome set: study protocol, systematic review of published outcomes, online Delphi survey, consensus workshop, and publication of core outcome set.